Ingevity Corp (NGVT) Stock Analysis and Metrics

Ingevity

NYSE: NGVT

$73.20 ▼ -0.56 (-0.76%)

At close: Jul 24, 2026 · 3:59 PM UTC

Financial Ratios

Market Cap2.57 Bn

P/E-22.73

P/S2.12

Div. Yield0.00

ROIC (Qtr)0.01

Total Debt (Qtr)1.20 Bn

Revenue Growth (1y) (Qtr)4.07

Add ratio to table…

About

Ingevity Corporation provides products and technologies that purify protect and enhance the world around us. The company develops manufactures and brings to market solutions that are largely renewably sourced and help customers solve complex problems while making the world more sustainable. Its products are used in automotive gasoline vapor emissions control systems, food, water and chemical filtration, asphalt paving, agrochemical dispersants, bioplastics, coatings, elastomers, and paint for road markings. Ingevity Corporation operates through three reportable segments Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.

Ingevity Corporation generates revenue by selling its activated carbon products, pavement technologies, road markings and caprolactone based specialty polymers. Its customers include automotive parts manufacturers, pavement and road marking contractors, agrochemical companies and bioplastics firms. Revenue is derived from product sales across its three reportable segments.

The company operates through the following segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.

• Performance Materials engineers manufactures and sells hardwood based chemically activated carbon products primarily for gasoline vapor emission control systems in internal combustion engines and hybrid electric vehicles, and for filtration applications in food, beverage, water and chemical purification.

• Performance Chemicals comprises pavement technologies and road markings product lines used in asphalt pavement construction, preservation, reconstruction, recycling and agrochemical dispersants.

• Advanced Polymer Technologies produces caprolactone and caprolactone based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics and medical applications.

In the activated carbon market Ingevity Corporation holds a strong position with competitors such as Norit, Kuraray Co Ltd, domestic US manufacturers and Chinese manufacturers. Its decades long track record of meeting life of vehicle emission standards provides a low risk choice for automotive customers and positions it well for increasingly stringent emissions standards worldwide. In pavement technologies the company faces competition from Nouryon Chemicals B V, Arkema S A and Zydex Group while its road markings business competes with Sherwin Williams Company and PPG Industries Traffic Solutions. Ingevity leverages deep customer relationships, extensive road building insights, and a reputation for reliable consistent performance to maintain a defensible market position. In the caprolactone segment Advanced Polymer Technologies competes with Daicel Corporation, Hunan Juren Chemical Hitechnology and BASF SE but differentiates itself through sustainability features such as high durability and biodegradability of its polymers and through customer intimacy and supply chain capabilities.

Ingevity Corporation serves a broad customer base that includes automotive parts manufacturers such as PHINIA Inc, A Kayser Automotive System GmbH, Korea Fuel Tech Corporation and MAHLE GmbH. Its food, water, beverage and chemical purification products are sold to approximately 70 customers globally. Performance Chemicals supplies pavement technologies to approximately 600 customers in 60 countries with top ten customers including Ergon Inc, Idaho Asphalt Supply Inc, The Heritage Group and Syngenta. Its road markings product line serves approximately 200 customers in North America with leading customers such as TRP Group and Frontline. Advanced Polymer Technologies sells to approximately 200 customers worldwide with major buyers active in polyurethane, elastomers, adhesives, coatings and bioplastics applications.

Investment Thesis

▲ Bull case

Ingevity is strategically positioned to benefit from the sustained global shift toward hybrid vehicles, which is not merely a North American phenomenon but a durable trend expanding into Europe and Asia as EV subsidies wane and consumer preferences evolve. The company's Performance Materials segment, which supplies advanced carbon solutions critical for hybrid vehicle emissions control, is experiencing meaningful tailwinds from this shift, with management confirming that hybrid adoption is accelerating globally due to reduced government incentives for pure EVs and increasing recognition of hybrids as a practical transitional technology. This structural demand driver supports higher-value product mix and pricing power, as evidenced by the 6% sales growth and 59% EBITDA margin in Performance Materials during Q1 FY26, with further upside potential as the company leverages its technical expertise to expand into adjacent high-growth markets like filtration, food and beverage, and medical applications—areas where it already has early traction but remains underpenetrated. The market appears to be underestimating the longevity and scalability of this hybrid-driven demand cycle, which could sustain above-segment growth for Performance Materials well beyond the current cycle, especially as Ingevity continues to innovate and deepen customer relationships in these emerging applications. The ongoing cost savings initiatives and portfolio simplification are not just defensive moves but enablers that will free up capital and management focus to accelerate investment in these higher-margin, long-term growth avenues, creating a compounding effect that is not fully reflected in current valuation multiples.
The divestiture of non-core assets—specifically Ozark Materials Road Markings and the North Charleston CTO refinery/Industrial Specialties businesses—is delivering immediate and underappreciated financial benefits that extend beyond the one-time cash proceeds of approximately $160 million. By shedding these lower-margin, volatile segments, Ingevity is significantly improving the quality and predictability of its earnings base, as evidenced by the uplift in Performance Chemicals EBITDA margin guidance from mid-teens to high teens post-divestiture, a change management explicitly highlighted as a direct result of removing the drag from Road Markings. This portfolio simplification is reducing earnings volatility and enhancing the comparability of core segment performance, allowing investors to more clearly see the strength of the Performance Materials and APT businesses. Furthermore, the elimination of approximately $15 million in annual indirect costs tied to the Industrial Specialties divestiture—on track to be achieved by year-end—represents a durable, run-rate EBITDA boost that is not yet fully priced into the stock, as these savings flow directly to the bottom line without requiring additional sales growth. The market may be viewing these divestitures as purely tactical, but they are fundamentally reshaping Ingevity into a leaner, more focused industrial specialty chemicals company with higher inherent profitability and lower capital intensity, a transformation that should support sustained multiple expansion as the company executes on its stated goal of reducing net leverage to 2–2.5x while maintaining aggressive share repurchases.
Advanced Polymer Technologies (APT) is experiencing a nascent but meaningful recovery driven by competitive disruptions in Asia stemming from the Middle East conflict, which has inadvertently created a temporary supply gap that Ingevity is capitalizing on through strengthened volume growth in the Asia Pacific region. While management cautiously characterized this as a transient factor, the sequential volume gains in APT—coupled with 5% sales growth in Q1 FY26 supported by favorable foreign exchange and the implementation of cost-offset surcharges—suggest that the segment is stabilizing faster than anticipated, with underlying demand beginning to recover after a prolonged period of weakness. The APT business, which generated $7.6 million in EBITDA at a 17.2% margin in Q1 FY26, remains a valuable asset with durable applications in adhesives, coatings, and elastomers, and its ongoing sale process has attracted strong interest, indicating that strategic buyers recognize its long-term value despite near-term headwinds. The market may be overlooking the potential for APT to deliver stronger-than-expected performance if the Middle East-related supply disruptions persist longer than modeled or if the segment’s recovery gains momentum, which could either enhance its standalone value or increase the proceeds from its eventual divestiture—both outcomes that would benefit shareholders through either improved core earnings or additional cash for debt reduction and share buybacks. The company’s ability to implement surcharges in response to raw material and energy cost pressures further demonstrates pricing resilience in APT, a capability that is underappreciated in current assessments of the segment’s vulnerability.

Ingevity is strategically positioned to benefit from the sustained global shift toward hybrid vehicles, which is not merely a North American phenomenon but a durable trend expanding into Europe and Asia as EV subsidies wane and consumer preferences evolve. The company's Performance Materials segment, which supplies advanced carbon solutions critical for hybrid vehicle emissions control, is experiencing meaningful tailwinds from this shift, with management confirming that hybrid adoption is accelerating globally due to reduced government incentives for pure EVs and increasing recognition of hybrids as a practical transitional technology. This structural demand driver supports higher-value product mix and pricing power, as evidenced by the 6% sales growth and 59% EBITDA margin in Performance Materials during Q1 FY26, with further upside potential as the company leverages its technical expertise to expand into adjacent high-growth markets like filtration, food and beverage, and medical applications—areas where it already has early traction but remains underpenetrated. The market appears to be underestimating the longevity and scalability of this hybrid-driven demand cycle, which could sustain above-segment growth for Performance Materials well beyond the current cycle, especially as Ingevity continues to innovate and deepen customer relationships in these emerging applications. The ongoing cost savings initiatives and portfolio simplification are not just defensive moves but enablers that will free up capital and management focus to accelerate investment in these higher-margin, long-term growth avenues, creating a compounding effect that is not fully reflected in current valuation multiples.
The divestiture of non-core assets—specifically Ozark Materials Road Markings and the North Charleston CTO refinery/Industrial Specialties businesses—is delivering immediate and underappreciated financial benefits that extend beyond the one-time cash proceeds of approximately $160 million. By shedding these lower-margin, volatile segments, Ingevity is significantly improving the quality and predictability of its earnings base, as evidenced by the uplift in Performance Chemicals EBITDA margin guidance from mid-teens to high teens post-divestiture, a change management explicitly highlighted as a direct result of removing the drag from Road Markings. This portfolio simplification is reducing earnings volatility and enhancing the comparability of core segment performance, allowing investors to more clearly see the strength of the Performance Materials and APT businesses. Furthermore, the elimination of approximately $15 million in annual indirect costs tied to the Industrial Specialties divestiture—on track to be achieved by year-end—represents a durable, run-rate EBITDA boost that is not yet fully priced into the stock, as these savings flow directly to the bottom line without requiring additional sales growth. The market may be viewing these divestitures as purely tactical, but they are fundamentally reshaping Ingevity into a leaner, more focused industrial specialty chemicals company with higher inherent profitability and lower capital intensity, a transformation that should support sustained multiple expansion as the company executes on its stated goal of reducing net leverage to 2–2.5x while maintaining aggressive share repurchases.
Advanced Polymer Technologies (APT) is experiencing a nascent but meaningful recovery driven by competitive disruptions in Asia stemming from the Middle East conflict, which has inadvertently created a temporary supply gap that Ingevity is capitalizing on through strengthened volume growth in the Asia Pacific region. While management cautiously characterized this as a transient factor, the sequential volume gains in APT—coupled with 5% sales growth in Q1 FY26 supported by favorable foreign exchange and the implementation of cost-offset surcharges—suggest that the segment is stabilizing faster than anticipated, with underlying demand beginning to recover after a prolonged period of weakness. The APT business, which generated $7.6 million in EBITDA at a 17.2% margin in Q1 FY26, remains a valuable asset with durable applications in adhesives, coatings, and elastomers, and its ongoing sale process has attracted strong interest, indicating that strategic buyers recognize its long-term value despite near-term headwinds. The market may be overlooking the potential for APT to deliver stronger-than-expected performance if the Middle East-related supply disruptions persist longer than modeled or if the segment’s recovery gains momentum, which could either enhance its standalone value or increase the proceeds from its eventual divestiture—both outcomes that would benefit shareholders through either improved core earnings or additional cash for debt reduction and share buybacks. The company’s ability to implement surcharges in response to raw material and energy cost pressures further demonstrates pricing resilience in APT, a capability that is underappreciated in current assessments of the segment’s vulnerability.

▼ Bear case

Ingevity’s free cash flow generation remains structurally challenged by recurring seasonal inventory builds and planned operational outages, with the negative $12 million free cash flow in Q1 FY26 highlighting a persistent pattern that management acknowledges may recur annually, undermining the reliability of its cash conversion and constraining its ability to fund share repurchases and debt reduction without relying on non-recurring divestiture proceeds. The company’s guidance for annual free cash flow of $215–$245 million excludes the $113 million in pretax litigation payments to BASF due in Q2, which will significantly impair near-term cash generation and potentially force a delay or scaling back of its $300 million share repurchase target through 2027 if operating performance does not exceed expectations. This dependency on divestitures to bolster cash flow—while simultaneously pursuing the sale of APT—creates a strategic tension: the company is monetizing assets to support shareholder returns, yet the very businesses being sold (or already sold) may have contributed to earnings stability, and the loss of these streams could leave Ingevity overly reliant on the cyclical Performance Materials segment. The market may be ignoring the risk that the anticipated free cash flow generation is overly optimistic, especially if inventory builds become more frequent due to supply chain volatility or if planned outages extend beyond current expectations, which would further erode cash conversion and increase working capital strain.
The Performance Chemicals segment, now reconstituted as Pavement Technologies following the Road Markings divestiture, continues to face inherent cyclicality and margin pressure that management’s improved outlook may not fully capture, despite the uplift to high-teens EBITDA margin guidance. The segment’s performance remains heavily tied to the timing and strength of the North American paving season, with approximately 70–75% of sales occurring in Q2 and Q3, making full-year results highly susceptible to weather delays, infrastructure spending fluctuations, and competitive pricing pressures—factors that were evident in Q1 FY26 where Pavement Technologies sales were flat despite price and mix gains due to lower volumes reflecting minor shifts in season timing. Although management cited inventory normalization ahead of Q2 outages as a temporary factor, the segment’s EBITDA margin remains highly sensitive to plant utilization and supply chain efficiencies, as demonstrated by the 1% margin in Q1 FY26 when Road Markings was still included, and any persistent weakness in utilization or unexpected cost inflation could prevent the segment from reaching the high-teens margin target, especially if the cost savings from Industrial Specialties divestiture are delayed or fall short of the $15 million run-rate goal. The market may be overestimating the durability of the margin improvement, assuming it is structural when it is largely driven by the removal of a low-margin business, without sufficient evidence that the core Pavement Technologies operations can sustainably operate at significantly higher profitability levels without ongoing cost discipline and favorable market conditions.
Ingevity’s reliance on price increases and surcharges to offset rising raw material and energy costs—particularly those linked to the Middle East conflict—represents a tactical response that may not be sustainable if cost pressures persist or intensify, and if customer resistance limits the company’s ability to pass through further increases, thereby squeezing margins. While management successfully implemented annual price increases in Performance Materials and introduced surcharges in APT during April to address cost inflation, the effectiveness of this strategy is contingent on maintaining strong customer relationships and minimal competitive displacement, which could be undermined if macroeconomic volatility leads to increased price sensitivity or if competitors gain advantage through lower-cost feedstocks or operational efficiencies. The APT segment, in particular, showed meaningful declines in EBITDA and margin due to lower plant utilization, and although volume growth in Asia Pacific provided a temporary boost, this was explicitly tied to competitors’ struggles from the Middle East conflict—a transient and geopolitical factor that could reverse rapidly if regional stability returns or if competitors adapt, leaving Ingevity exposed to renewed demand weakness. Furthermore, the company’s acknowledgment that it is “pretty well insulated” from macroeconomic uncertainty outside of APT suggests a degree of complacency, as even its core Performance Materials business could face headwinds if the hybrid vehicle trend slows due to technological advancements in pure EVs, changes in consumer preferences, or shifts in regulatory policy that favor battery-electric over hybrid solutions, which would directly undermine the primary growth driver cited for the segment.

Ingevity’s free cash flow generation remains structurally challenged by recurring seasonal inventory builds and planned operational outages, with the negative $12 million free cash flow in Q1 FY26 highlighting a persistent pattern that management acknowledges may recur annually, undermining the reliability of its cash conversion and constraining its ability to fund share repurchases and debt reduction without relying on non-recurring divestiture proceeds. The company’s guidance for annual free cash flow of $215–$245 million excludes the $113 million in pretax litigation payments to BASF due in Q2, which will significantly impair near-term cash generation and potentially force a delay or scaling back of its $300 million share repurchase target through 2027 if operating performance does not exceed expectations. This dependency on divestitures to bolster cash flow—while simultaneously pursuing the sale of APT—creates a strategic tension: the company is monetizing assets to support shareholder returns, yet the very businesses being sold (or already sold) may have contributed to earnings stability, and the loss of these streams could leave Ingevity overly reliant on the cyclical Performance Materials segment. The market may be ignoring the risk that the anticipated free cash flow generation is overly optimistic, especially if inventory builds become more frequent due to supply chain volatility or if planned outages extend beyond current expectations, which would further erode cash conversion and increase working capital strain.
The Performance Chemicals segment, now reconstituted as Pavement Technologies following the Road Markings divestiture, continues to face inherent cyclicality and margin pressure that management’s improved outlook may not fully capture, despite the uplift to high-teens EBITDA margin guidance. The segment’s performance remains heavily tied to the timing and strength of the North American paving season, with approximately 70–75% of sales occurring in Q2 and Q3, making full-year results highly susceptible to weather delays, infrastructure spending fluctuations, and competitive pricing pressures—factors that were evident in Q1 FY26 where Pavement Technologies sales were flat despite price and mix gains due to lower volumes reflecting minor shifts in season timing. Although management cited inventory normalization ahead of Q2 outages as a temporary factor, the segment’s EBITDA margin remains highly sensitive to plant utilization and supply chain efficiencies, as demonstrated by the 1% margin in Q1 FY26 when Road Markings was still included, and any persistent weakness in utilization or unexpected cost inflation could prevent the segment from reaching the high-teens margin target, especially if the cost savings from Industrial Specialties divestiture are delayed or fall short of the $15 million run-rate goal. The market may be overestimating the durability of the margin improvement, assuming it is structural when it is largely driven by the removal of a low-margin business, without sufficient evidence that the core Pavement Technologies operations can sustainably operate at significantly higher profitability levels without ongoing cost discipline and favorable market conditions.
Ingevity’s reliance on price increases and surcharges to offset rising raw material and energy costs—particularly those linked to the Middle East conflict—represents a tactical response that may not be sustainable if cost pressures persist or intensify, and if customer resistance limits the company’s ability to pass through further increases, thereby squeezing margins. While management successfully implemented annual price increases in Performance Materials and introduced surcharges in APT during April to address cost inflation, the effectiveness of this strategy is contingent on maintaining strong customer relationships and minimal competitive displacement, which could be undermined if macroeconomic volatility leads to increased price sensitivity or if competitors gain advantage through lower-cost feedstocks or operational efficiencies. The APT segment, in particular, showed meaningful declines in EBITDA and margin due to lower plant utilization, and although volume growth in Asia Pacific provided a temporary boost, this was explicitly tied to competitors’ struggles from the Middle East conflict—a transient and geopolitical factor that could reverse rapidly if regional stability returns or if competitors adapt, leaving Ingevity exposed to renewed demand weakness. Furthermore, the company’s acknowledgment that it is “pretty well insulated” from macroeconomic uncertainty outside of APT suggests a degree of complacency, as even its core Performance Materials business could face headwinds if the hybrid vehicle trend slows due to technological advancements in pure EVs, changes in consumer preferences, or shifts in regulatory policy that favor battery-electric over hybrid solutions, which would directly undermine the primary growth driver cited for the segment.

Segments Breakdown of Revenue (2025)

Peer Comparison

Companies in the Specialty Chemicals

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	LIN	Linde Plc	237.95 Bn	33.52	6.87	24.68 Bn
2	SHW	Sherwin Williams Co	78.17 Bn	30.07	3.27	11.70 Bn
3	ECL	Ecolab Inc.	76.02 Bn	30.01	4.73	8.24 Bn
4	APD	Air Products & Chemicals, Inc.	66.38 Bn	47.14	5.33	17.40 Bn
5	PPG	Ppg Industries Inc	26.02 Bn	3,717.41	1.61	7.83 Bn
6	LYB	LyondellBasell Industries N.V.	22.51 Bn	-28.53	0.76	11.45 Bn
7	SQM	Chemical & Mining Co Of Chile Inc	19.70 Bn	21.77	3.72	4.79 Bn
8	IFF	International Flavors & Fragrances Inc	19.51 Bn	-102.16	1.81	5.82 Bn

Research Tools

Developers

About

Investment Thesis

Geographical Breakdown of Revenue (2025)

Segments Breakdown of Revenue (2025)

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Geographical Breakdown of Revenue (2025)

Segments Breakdown of Revenue (2025)

Peer Comparison

Create an account

Sign In

Reset Password